Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Respiratory Research
|
September 13, 2019
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
R James White, Anton Vonk-Noordegraaf, Stephan Rosenkranz, et al.
Circulation
|
March 23, 2011
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association
Michael R Jaff, M Sean McMurtry, Stephen L Archer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 26, 2007
Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension
R James White, David F Meoli, Robert F Swarthout, et al.
Chest
|
December 2, 2024
Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities
R James White, Karim El-Kersh, Stephan Rosenkranz, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 5, 2021
Reduced Notch1 Cleavage Promotes the Development of Pulmonary Hypertension
Shumin Wang, Guofu Zhu, Dongyang Jiang, et al.
Journal of Thrombosis and Thrombolysis
|
May 19, 2019
The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department
Colin Wright, Ayman Elbadawi, Yu Lin Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 11, 2020
Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Richard D Bell, R James White, Maria L Garcia-Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Raymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 26, 2019
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial
R James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis
Alexi Crosby, Elaine Soon, Frances M Jones, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Respiratory Research
|
September 13, 2019
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
R James White, Anton Vonk-Noordegraaf, Stephan Rosenkranz, et al.
Circulation
|
March 23, 2011
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association
Michael R Jaff, M Sean McMurtry, Stephen L Archer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 26, 2007
Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension
R James White, David F Meoli, Robert F Swarthout, et al.
Chest
|
December 2, 2024
Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities
R James White, Karim El-Kersh, Stephan Rosenkranz, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 5, 2021
Reduced Notch1 Cleavage Promotes the Development of Pulmonary Hypertension
Shumin Wang, Guofu Zhu, Dongyang Jiang, et al.
Journal of Thrombosis and Thrombolysis
|
May 19, 2019
The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department
Colin Wright, Ayman Elbadawi, Yu Lin Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 11, 2020
Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Richard D Bell, R James White, Maria L Garcia-Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Raymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 26, 2019
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial
R James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis
Alexi Crosby, Elaine Soon, Frances M Jones, et al.
Page
of 7